{"id":"W4200437485","doi":"10.3390/ph14121270","title":"Expanding the Use of PARP Inhibitors as Monotherapy and in Combination in Triple-Negative Breast Cancer","year":2021,"lang":"en","type":"review","venue":"Pharmaceuticals","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; BRCA mutation; PARP inhibitor; Metastatic breast cancer; Oncology; Chemotherapy; Internal medicine; Cancer; Cancer research; Poly ADP ribose polymerase; Polymerase; Biology; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005606929,0.0003292466,0.001547122,0.0003584476,0.00003518862,0.00003313348,0.00009323239,0.0002088279,0.0004301292],"category_scores_gemma":[0.0001500926,0.0002341821,0.0002000889,0.0009068077,0.0002153895,0.0001451728,0.0000445081,0.0007050284,0.000004315583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004700929,"about_ca_system_score_gemma":0.0004212047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002152707,"about_ca_topic_score_gemma":0.0000285456,"domain_scores_codex":[0.9974327,0.0006336888,0.0009136958,0.0004047389,0.0003326143,0.000282576],"domain_scores_gemma":[0.9980276,0.001168838,0.0003430431,0.0002434489,0.0001050514,0.0001120813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000297411,0.0003444354,0.00127407,0.003967612,0.0002696618,0.00004861188,0.0007700198,0.000005841994,0.0001286125,0.0001531682,0.0005597745,0.9921808],"study_design_scores_gemma":[0.01067615,0.00008667161,0.0006921859,0.06029838,0.0007212008,0.0002284928,0.0001750491,0.0001506434,0.002763817,0.0002622914,0.9233922,0.0005529231],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00314919,0.9929678,0.00001124501,0.001370526,0.0002737605,0.002018497,0.0001195718,0.00001675672,0.00007267798],"genre_scores_gemma":[0.003368487,0.9948306,0.0000573241,0.0007561329,0.0001376179,0.0006597899,0.00002785436,0.00005240095,0.0001097848],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9916279,"threshold_uncertainty_score":0.9549667,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2316399911823588,"score_gpt":0.492579449085121,"score_spread":0.2609394579027622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}